Brain insulin resistance thus contributes to AD, a complex phenomenon accompanied by IGF-1 resistance and dysfunction of IRS-1 triggered by amyloid-β oligomers, stimulating cognitive decline independent of AD pathology83. This evidence concerns the gene IRS1 and Alzheimer disease.